Literature DB >> 30102075

A cross-sectional study in young adults with psoriasis: potential determining factors in quality of life, life course and work productivity.

Inge M G J Bronckers1, Maartje J van Geel1, Peter C M van de Kerkhof1, Elke M G J de Jong1, Marieke M B Seyger1.   

Abstract

BACKGROUND: Psoriasis can have a substantial impact on health-related quality of life (HRQoL), life course, and work productivity. Young adulthood is a critical, sensitive period of development that includes major life changing decisions. The impact of psoriasis on this vulnerable population is yet unknown.
OBJECTIVES: To assess QoL, life course, and work productivity in young adults with psoriasis and identify characteristics influencing these patient-reported outcomes (PRO).
METHODS: An explorative, cross-sectional study was performed in psoriasis patients aged 18-30 years. Individuals completed a set of questionnaires regarding their health status (DLQI, SF-36, EQ-5D), achievement of developmental milestones (COLQ), and work productivity (WPAI-PSO, PRODISQ).
RESULTS: Seventy-five patients (22 males, 53 females; median age [IQR], 21.0 [8.0]). Median PASI and BSA, respectively, were 4.4 [4.9] and 4.5 [8.4]. Young adults experienced feelings of embarrassment, impairments in physical health and work productivity, and difficulties in social development. Patients with more severe psoriasis, longer disease duration, higher body mass index (BMI), female patients and patients closer to their thirties tended to be more affected.
CONCLUSION: In the young adult psoriasis population, substantial QoL impairments were found. Female patients, patients with high BMI, or long disease duration in particular tended to experience more difficulties. These exploratory findings indicate the need for further studies in young adults to detect potential clinical predictors for severe HRQoL impairments.

Entities:  

Keywords:  Health-related quality of life; life course impairment; psoriasis; work productivity; young adults

Mesh:

Year:  2018        PMID: 30102075     DOI: 10.1080/09546634.2018.1506077

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  6 in total

1.  Psychosocial aspects of obesity in adults with psoriasis: A systematic review.

Authors:  N T Pavlova; K Kioskli; C Smith; F Picariello; L Rayner; R Moss-Morris
Journal:  Skin Health Dis       Date:  2021-05-03

2.  A multinational assessment of work-related productivity loss and indirect costs from a survey of patients with psoriasis.

Authors:  R Villacorta; A Teeple; S Lee; S Fakharzadeh; J Lucas; S McElligott
Journal:  Br J Dermatol       Date:  2020-01-29       Impact factor: 9.302

3.  Drug survival of ixekizumab, TNF inhibitors, and other IL-17 inhibitors in real-world patients with psoriasis: The Corrona Psoriasis Registry.

Authors:  Benjamin Lockshin; Angel Cronin; Ryan W Harrison; Robert R McLean; Laura Anatale-Tardiff; Russel Burge; Baojin Zhu; William N Malatestinic; Bilal Atiya; Mwangi J Murage; Gaia Gallo; Bruce Strober; Abby Van Voorhees
Journal:  Dermatol Ther       Date:  2021-02-15       Impact factor: 2.851

4.  The remarkably frequent use of EQ-5D in non-economic research.

Authors:  Aimin Wang; Kim Rand; Zhihao Yang; Richard Brooks; Jan Busschbach
Journal:  Eur J Health Econ       Date:  2021-11-30

5.  Burden and Disease Characteristics of Psoriatic Arthritis at a Tertiary Center.

Authors:  Suzan Attar; Amjad M Almanmmas; Shabab M Alamri; Ahmad W Sindi; Majed T Jobah; Marwan A Bader; Abdulrahman K Alghamdi; Majd Z Sahhaf; Turki A AlAmoudi
Journal:  Cureus       Date:  2022-07-27

6.  Treatment persistence in paediatric and adolescent patients with psoriasis followed into young adulthood. From topical to systemic treatment: a prospective, longitudinal, observational cohort study of 448 patients.

Authors:  F M Bruins; I M G J Bronckers; R Cai; J M M Groenewoud; M Krol; E M G J de Jong; M M B Seyger
Journal:  Br J Dermatol       Date:  2020-07-29       Impact factor: 9.302

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.